Becton, Dickinson and Company Stock Nyse
Equities
BDXA
US0758872081
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-5.43% | -9.50% |
Sales 2024 * | 20.25B 27.7B | Sales 2025 * | 21.47B 29.38B | Capitalization | 66.25B 90.63B |
---|---|---|---|---|---|
Net income 2024 * | 2.09B 2.86B | Net income 2025 * | 2.48B 3.39B | EV / Sales 2024 * | 3.92 x |
Net Debt 2024 * | 13.13B 17.96B | Net Debt 2025 * | 10.8B 14.77B | EV / Sales 2025 * | 3.59 x |
P/E ratio 2024 * |
32.2
x | P/E ratio 2025 * |
28.5
x | Employees | - |
Yield 2024 * |
1.64% | Yield 2025 * |
1.68% | Free-Float | 77.74% |
Latest transcript on Becton, Dickinson and Company
Managers | Title | Age | Since |
---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 08-12-31 |
Director of Finance/CFO | 52 | 21-09-05 | |
Chief Tech/Sci/R&D Officer | 48 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 02-09-23 |
Catherine Burzik
BRD | Director/Board Member | 73 | 13-01-28 |
Director/Board Member | 69 | 10-07-25 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.24% | 180B | |
-6.08% | 99.21B | |
-9.35% | 44.74B | |
+8.34% | 43.82B | |
+10.35% | 41.96B | |
+11.88% | 28.98B | |
-8.38% | 23.5B | |
+16.18% | 24.07B | |
-12.68% | 21.86B |
- Stock Market
- Equities
- BDX Stock
- BDXA Stock